(S1 (S (S (VP (VBG Promoting) (NP (NN angiogenesis)) (PP (IN via) (NP (NP (NN manipulation)) (PP (IN of) (NP (NN VEGF) (NN responsiveness))) (PP (IN with) (NP (NN notch) (NN signaling))))))) (. .)))
(S1 (S (S (S (VP (VBG Promoting) (NP (NN angiogenesis)) (PP (IN via) (NP (NP (NN delivery)) (PP (IN of) (NP (NP (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN VEGF)) (-RRB- -RRB-))) (CC and) (NP (JJ other) (JJ angiogenic) (NNS factors)))))))) (VP (VBZ is) (NP (CC both) (NP (NP (DT a) (JJ potential) (NN therapy)) (PP (IN for) (NP (JJ cardiovascular) (NNS diseases)))) (CC and) (NP (NP (DT a) (JJ critical) (NN aspect)) (PP (IN for) (NP (NN tissue) (NN regeneration))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ recent) (NN demonstration)) (SBAR (IN that) (S (NP (NN VEGF) (NN signaling)) (VP (VBZ is) (VP (VBN modulated) (PP (IN by) (NP (DT the) (NN Notch) (NN signaling) (NN pathway)))))))) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ suggests) (SBAR (IN that) (S (S (VP (VBG inhibiting) (NP (NN Notch) (NN signaling)))) (VP (MD may) (VP (VB enhance) (NP (JJ regional) (NN neovascularization)) (, ,) (PP (IN by) (S (VP (VBG altering) (NP (NP (DT the) (NN responsiveness)) (PP (IN of) (NP (JJ local) (JJ endothelial) (NNS cells))) (PP (TO to) (NP (JJ angiogenic) (NNS stimuli))))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBD tested) (NP (DT this) (NN possibility)) (PP (IN with) (NP (NP (ADJP (FW in) (FW vitro)) (NNS assays)) (VP (VP (VBG using) (NP (JJ human) (JJ endothelial) (NNS cells))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (DT a) (JJ rodent) (NN hindlimb) (NN ischemia) (NN model)))))))) (. .)))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (VBN cultured) (JJ human) (JJ endothelial) (NNS cells))) (PP (IN with) (NP (NP (NN DAPT)) (, ,) (NP (DT a) (NN gamma) (NN secretase) (NN inhibitor)) (, ,)))) (VP (VBD increased) (NP (NP (NN cell) (NN migration)) (CC and) (NP (NN sprout) (NN formation))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN VEGF) (NN stimulation)) (PP (IN with) (NP (NP (DT a) (JJ biphasic) (NN dependence)) (PP (IN on) (NP (NN DAPT) (NN concentration))))))))))) (. .)))
(S1 (S (S (ADVP (RB Further)) (, ,) (NP (NP (NN delivery)) (PP (IN of) (NP (NP (DT an) (JJ appropriate) (NN combination)) (PP (IN of) (NP (NP (NN DAPT)) (CC and) (NP (NN VEGF)))))) (PP (IN from) (NP (DT an) (JJ injectable) (NN alginate) (NN hydrogel) (NN system))) (PP (IN into) (NP (JJ ischemic) (NNS hindlimbs)))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (JJR faster) (NN recovery)) (PP (IN of) (NP (NN blood) (NN flow))) (PP (IN than) (NP (NP (NP (NN VEGF)) (CC or) (NP (NN DAPT))) (ADVP (RB alone)))))))) (: ;) (S (NP (NN perfusion) (NNS levels)) (VP (VBD reached) (NP (NP (CD 80) (NN %)) (PP (IN of) (NP (DT the) (JJ normal) (NN level)))) (PP (IN by) (NP (NN week) (CD 4))) (PP (IN with) (NP (NP (JJ combined) (NN DAPT)) (CC and) (NP (NN VEGF) (NN delivery)))))) (. .)))
(S1 (S (S (NP (NP (JJ Direct) (JJ intramuscular) (CC or) (JJ intraperitoneal) (NN injection)) (PP (IN of) (NP (NN DAPT)))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT the) (JJ same) (NN level)) (PP (IN of) (NP (NN improvement)))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (JJ appropriate) (NN presentation)) (PP (IN of) (NP (NP (NN DAPT)) (PRN (-LRB- -LRB-) (NP (NN gel) (NN delivery)) (-RRB- -RRB-))))) (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (NP (PRP$ its) (NN activity))))))))))) (. .)))
(S1 (S (S (NP (NP (NN DAPT) (NN delivery)) (PP (IN from) (NP (DT the) (NNS hydrogels)))) (ADVP (RB also)) (VP (VBD did) (RB not) (VP (VB lead) (PP (TO to) (NP (DT any) (JJ adverse) (JJ side) (NNS effects))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NP (JJ systemic) (NN introduction)) (PP (IN of) (NP (NN DAPT)))))))) (. .)))
(S1 (S (ADVP (RB Altogether)) (, ,) (NP (DT these) (NNS results)) (VP (VP (VBP suggest) (NP (NP (DT a) (JJ new) (NN approach)) (S (VP (TO to) (VP (VB promote) (NP (NN angiogenesis)) (PP (IN by) (S (VP (VBG controlling) (NP (NN Notch) (NN signaling)))))))))) (, ,) (CC and) (VP (MD may) (VP (VB provide) (NP (JJ new) (NNS options))) (S (VP (TO to) (VP (VB treat) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS diseases)) (SBAR (WHNP (WDT that)) (S (VP (VB diminish) (NP (JJ angiogenic) (NN responsiveness))))))))))))) (. .)))
